Cargando…

No impact of IL28B polymorphisms on liver enzymes in patients coinfected with HIV and HCV

Detalles Bibliográficos
Autores principales:	Fernández-Montero, JV, Martín-Carbonero, L, Barreiro, P, Rallón, NI, Benito, JM, González-Lahoz, J, Soriano, V
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The International AIDS Society 2010
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3112990/ http://dx.doi.org/10.1186/1758-2652-13-S4-P206

Ejemplares similares

Do interleukin-28B single nucleotide polymorphisms influence the natural history of chronic hepatitis B?
por: Martín-Carbonero, L, et al.
Publicado: (2010)

Sustained virological response in HIV/HCV co-infected patients without rapid virological response (RVR) on peginterferon-ribavirin therapy
por: Labarga, P, et al.
Publicado: (2010)

Relationship of TRIM5 and TRIM22 polymorphisms with liver disease and HCV clearance after antiviral therapy in HIV/HCV coinfected patients
por: Medrano, Luz M., et al.
Publicado: (2016)

Mitral valve endocarditis in an IV ethnobotanical drug user coinfected with HIV-HCV
por: Popa, Ionut, et al.
Publicado: (2014)

Host genetics of HCV disease — IL28B
por: Fellay, J
Publicado: (2010)

Changes in immune activation in the T Cell compartments of HIV HCV coinfected patients during PEG IFN RBV treatment
por: Menard, Amélie, et al.
Publicado: (2012)

HCV coinfection contributes to HIV pathogenesis by increasing immune exhaustion in CD8 T-cells
por: Rallón, Norma, et al.
Publicado: (2017)

Efficacy and safety of hepatitis C direct-acting protease inhibitors (DAA-PI ) in real life in HIV-HCV coinfected patients
por: Ménard, A, et al.
Publicado: (2014)

Liver Enzyme Alterations in HCV-Monoinfected and HCV/HIV-Coinfected Patients
por: Langohr, Klaus, et al.
Publicado: (2008)

Pharmacogenetics of Efficacy and Safety of HCV Treatment in HCV-HIV Coinfected Patients: Significant Associations with IL28B and SOCS3 Gene Variants
por: Vidal, Francesc, et al.
Publicado: (2012)

Effects on insulin sensitivity and hepatic safety of Atazanavir in HCV/HIV coinfected patients versus HIV monoinfected: A prostective 48-week study
por: Meijide, Héctor, et al.
Publicado: (2010)

HIV-reservoir size is not affected either by HCV coinfection or by direct acting antivirals (DAAs) therapy
por: Álvarez, Beatriz, et al.
Publicado: (2022)

Liver Stiffness Hinders Normalization of Systemic Inflammation and Endothelial Activation after Hepatitis C Virus (HCV) Eradication in HIV/HCV Coinfected Patients
por: Álvarez, Beatriz, et al.
Publicado: (2020)

Liver safety of two nucleoside analogs plus efavirenz, nevirapine or a ritonavir-boosted protease inhibitor in HIV/HCV-coinfected drug-naïve patients
por: Macías, J, et al.
Publicado: (2010)

Impact of Immunogenetic IL28B Polymorphism on Natural Outcome of HCV Infection
por: De Re, Valli, et al.
Publicado: (2014)

Tryptophan Breakdown in Patients with HCV Infection is Influenced by IL28B Polymorphism
por: Zoller, Heinz, et al.
Publicado: (2015)

Efficacy and safety of TDF+FTC+EFV in naïve patients initiating HAART; an observational study comparing Atripla Vs Truvada/Sustiva exposure
por: Sanchez, Carlos Alberto, et al.
Publicado: (2010)

HCV-coinfection is related to an increased HIV-1 reservoir size in cART-treated HIV patients: a cross-sectional study
por: López-Huertas, Maria Rosa, et al.
Publicado: (2019)

IL28B gene polymorphisms in mono- and HIV-coinfected chronic hepatitis C patients
por: Bertol, Bruna C., et al.
Publicado: (2015)

HCV Specific IL-21 Producing T Cells but Not IL-17A Producing T Cells Are Associated with HCV Viral Control in HIV/HCV Coinfection
por: MacParland, Sonya A., et al.
Publicado: (2016)

HTLV-1 infection modulates the immune response in HIV-HCV coinfected patients and may increase spontaneous HCV clearance
por: Bahia, Fabianna, et al.
Publicado: (2014)

Glomerular filtration (GF) determined by creatinine clearance (CCR) in 24 hours urine and cockcroft & gault (cg) and modification of diet in renal disease (MDRD) equations in a large cohort of HIV+ patients
por: Labarga, Pablo, et al.
Publicado: (2010)

Hepatitis C virus (HCV) infection and re-infection among HCV- and HIV/HCV-infected injection drug users
por: Conway, B, et al.
Publicado: (2010)

Absence of association of IFNL3/IL28B rs 12979860 and IFNL4 ss 469415590 polymorphisms with the neurological status of HTLV-1 Afro-Caribbean subjects in Martinique.
por: Jeannin, Severine, et al.
Publicado: (2015)

Absence of association of IFNL3/IL28B rs 12979860 and IFNL4 ss 469415590 polymorphisms with the neurological status of HTLV-1 Afro-Caribbean subjects in Martinique.
por: Jeannin, Severine, et al.
Publicado: (2015)

P02-02. Analysis of antigen specific degranulation potentials using IL-12 or IL-28B during HIV DNA Vaccination
por: Morrow, M, et al.
Publicado: (2009)

Impact of Raltegravir on immune reconstitution and thymopoiesis in HIV-1-infected patients with undetectable viremia
por: Garrido, C, et al.
Publicado: (2010)

Hepatitis B coinfection in HIV-infected patients
por: Jugănariu, Gabriela, et al.
Publicado: (2013)

Chances for cure in chronic HBV/HDV coinfection
por: Iliescu, Gabriela, et al.
Publicado: (2014)

HCV-related liver and lymphoproliferative diseases: association with polymorphisms of IL28B and TLR2
por: De Re, Valli, et al.
Publicado: (2016)

IL28B Alleles Exert an Additive Dose Effect When Applied to HCV-HIV Coinfected Persons Undergoing Peginterferon and Ribavirin Therapy
por: Abu Dayyeh, Barham K., et al.
Publicado: (2011)

Managing HCV/HIV coinfection
por: Danish, Fazal A., et al.
Publicado: (2009)

Pharmacologic management of HCV treatment in patients with HCV monoinfection vs. HIV/HCV coinfection: Does coinfection really matter?
por: Zuckerman, Autumn D., et al.
Publicado: (2019)

Boceprevir (BOC) and Telaprevir (TPV) therapeutic drug monitoring in HCV and HIV-HCV infected patients treated with triple therapy Ribavirine/Peg-interferon/Boceprevir or Telaprevir: impact of the antiretroviral (ARV) treatment
por: Chantry, AS, et al.
Publicado: (2014)

Implications of hcv natural genetic diversity on HCV NS5B inhibitor NM283
por: Demetriou, Victoria L, et al.
Publicado: (2010)

ADAR1 polymorphisms are related to severity of liver fibrosis in HIV/HCV-coinfected patients
por: Medrano, Luz M., et al.
Publicado: (2017)

Carcinovic cohort: prognostic factors of death in HIV/HCV coinfected patients with hepatocellular carcinoma (HCC)
por: Gelu-Simeon, M, et al.
Publicado: (2014)

Role of regulatory proteins in HIV-1/HTLV-1 coinfection
por: Edwards, Dustin, et al.
Publicado: (2014)

Low reduction of HCV-RNA level at week 4 in HIV-1 infected patients with acute HCV Infection
por: Vincent, A, et al.
Publicado: (2012)

Antiviral resistance in HCV strains isolated from Romanian patients with limited treatment options for chronic HCV infection
por: Streinu-Cercel, Anca, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_1qfg036u4ok4p8k4jlp6pdj2c3